Munafa Stock Market Course + Intraday & FNO calls 
GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2296.85 and 2352.25
| Intraday Target 1 | 2255.83 |
| Intraday Target 2 | 2282.47 |
| Intraday Target 3 | 2311.2333333333 |
| Intraday Target 4 | 2337.87 |
| Intraday Target 5 | 2366.63 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Tue 24 March 2026 | 2309.10 (1.31%) | 2301.00 | 2284.60 - 2340.00 | 1.2036 times | Mon 23 March 2026 | 2279.20 (-4.43%) | 2353.40 | 2269.10 - 2364.90 | 1.1948 times | Fri 20 March 2026 | 2384.80 (0.34%) | 2376.80 | 2362.50 - 2416.00 | 1.3798 times | Thu 19 March 2026 | 2376.70 (-2.5%) | 2401.00 | 2372.40 - 2419.60 | 0.5394 times | Wed 18 March 2026 | 2437.60 (0.33%) | 2428.90 | 2418.20 - 2472.00 | 0.6183 times | Tue 17 March 2026 | 2429.60 (1.11%) | 2404.90 | 2396.00 - 2440.00 | 0.7304 times | Mon 16 March 2026 | 2403.00 (-0.88%) | 2413.00 | 2379.20 - 2432.40 | 1.0265 times | Fri 13 March 2026 | 2424.30 (-3.2%) | 2500.00 | 2397.70 - 2500.00 | 1.2055 times | Thu 12 March 2026 | 2504.40 (0.74%) | 2486.00 | 2436.80 - 2519.40 | 1.102 times | Wed 11 March 2026 | 2486.00 (-0.04%) | 2489.50 | 2471.00 - 2541.00 | 0.9997 times | Tue 10 March 2026 | 2487.00 (-1.28%) | 2527.00 | 2473.00 - 2554.00 | 1.4098 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2241.2 and 2337
| Weekly Target 1 | 2218.57 |
| Weekly Target 2 | 2263.83 |
| Weekly Target 3 | 2314.3666666667 |
| Weekly Target 4 | 2359.63 |
| Weekly Target 5 | 2410.17 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Tue 24 March 2026 | 2309.10 (-3.17%) | 2353.40 | 2269.10 - 2364.90 | 0.3403 times | Fri 20 March 2026 | 2384.80 (-1.63%) | 2413.00 | 2362.50 - 2472.00 | 0.6093 times | Fri 13 March 2026 | 2424.30 (-3.69%) | 2500.00 | 2397.70 - 2554.00 | 0.818 times | Fri 06 March 2026 | 2517.30 (-2.11%) | 2520.00 | 2450.10 - 2581.60 | 0.7909 times | Fri 27 February 2026 | 2571.60 (-0.97%) | 2616.80 | 2566.00 - 2668.80 | 0.7896 times | Fri 20 February 2026 | 2596.90 (0.1%) | 2590.00 | 2558.10 - 2644.00 | 0.8736 times | Fri 13 February 2026 | 2594.40 (4.44%) | 2489.00 | 2475.00 - 2719.80 | 2.2646 times | Fri 06 February 2026 | 2484.00 (3.43%) | 2421.40 | 2342.10 - 2489.00 | 1.158 times | Fri 30 January 2026 | 2401.60 (3.81%) | 2319.00 | 2278.30 - 2442.90 | 1.0268 times | Fri 23 January 2026 | 2313.40 (-1.36%) | 2345.90 | 2220.30 - 2420.00 | 1.3289 times | Fri 16 January 2026 | 2345.40 (-1.13%) | 2372.00 | 2337.60 - 2417.10 | 0.7268 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2132.85 and 2445.35
| Monthly Target 1 | 2074.1 |
| Monthly Target 2 | 2191.6 |
| Monthly Target 3 | 2386.6 |
| Monthly Target 4 | 2504.1 |
| Monthly Target 5 | 2699.1 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Tue 24 March 2026 | 2309.10 (-10.21%) | 2520.00 | 2269.10 - 2581.60 | 0.4171 times | Fri 27 February 2026 | 2571.60 (7.08%) | 2421.40 | 2342.10 - 2719.80 | 0.8292 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.7407 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 1.2105 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 1.0096 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.6556 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 1.0443 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.4452 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 0.8824 times | Mon 30 June 2025 | 3388.10 (2.71%) | 3298.00 | 3153.90 - 3515.70 | 1.7655 times | Fri 30 May 2025 | 3298.60 (11.27%) | 2935.30 | 2693.90 - 3398.00 | 3.1704 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2014.95 and 2514.45
| Yearly Target 1 | 1916.9 |
| Yearly Target 2 | 2113 |
| Yearly Target 3 | 2416.4 |
| Yearly Target 4 | 2612.5 |
| Yearly Target 5 | 2915.9 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Tue 24 March 2026 | 2309.10 (-6.65%) | 2476.00 | 2220.30 - 2719.80 | 0.2063 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.6574 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.2592 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.2559 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7295 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.973 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0859 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4645 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2362 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1321 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1324 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in downtrend.
And this trend seems to be continuing further.Price is below an important level of 2405.57 on charts, and if price remains below this level, then stock might show a fall in short term.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO made a major fall in previous days. This happens when sentiment changes towards negative. This fall might deepen in coming days.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO is bearish. The stock has broken weekly support. An up move can be expected only after it starts trading above 2318.9
Munafa value: 15 as on Tue 24 March 2026
This Munafa value indicates that the stock is moving downwards and might continue to move down.
SMA20 is at 2477 and price is deviating by 97 points
Upper Bollinger band is at 2670 and lower is at 2283, while middle bands are at 2380 and 2573
Price is rising
Price is below 20day SMA
Price is in lower range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and the sell signal is strong.
GlaxosmithklinePharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for GlaxosmithklinePharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of GlaxosmithklinePharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2399.1 and GlaxosmithklinePharmaceuticals GLAXO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2357.48 |
| 12 day DMA | 2420.08 |
| 20 day DMA | 2476.22 |
| 35 day DMA | 2514.13 |
| 50 day DMA | 2468.68 |
| 100 day DMA | 2495.14 |
| 150 day DMA | 2582.08 |
| 200 day DMA | 2724.32 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2346.66 | 2365.44 | 2408.56 |
| 12 day EMA | 2405.57 | 2423.1 | 2449.26 |
| 20 day EMA | 2441.6 | 2455.54 | 2474.09 |
| 35 day EMA | 2450.72 | 2459.06 | 2469.65 |
| 50 day EMA | 2454.29 | 2460.21 | 2467.59 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2357.48 | 2381.58 | 2406.34 |
| 12 day SMA | 2420.08 | 2437.43 | 2454.1 |
| 20 day SMA | 2476.22 | 2492.69 | 2508.58 |
| 35 day SMA | 2514.13 | 2516.94 | 2520.63 |
| 50 day SMA | 2468.68 | 2469.94 | 2472.33 |
| 100 day SMA | 2495.14 | 2498.47 | 2502.26 |
| 150 day SMA | 2582.08 | 2585.15 | 2588.44 |
| 200 day SMA | 2724.32 | 2730.1 | 2735.81 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 56.39 and PE is: 40.95
Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)
Debt: 35.71 in crores
Market capitalization: 43709.18
EPS is 56.09 and PE is: 41.17
Last quarter profit: (June 2025 quarter) 205.01 crores (12.44%)
Debt: 9.95 in crores
Market capitalization: 47197.61
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
